Cite
Terslev L, Brahe CH, Hetland ML, et al. Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission. Rheumatology (Oxford). 2021;60(12):5549-5559doi: 10.1093/rheumatology/keab276.
Terslev, L., Brahe, C. H., Hetland, M. L., Georgiadis, S., Ellegaard, K., Juul, L., Huynh, T., Døhn, U. M., Fana, V., Møller, T., Krabbe, S., Ørnbjerg, L. M., Glinatsi, D., Røgind, H., Hansen, A., Nørregaard, J., Jacobsen, S., Jensen, D. V., Manilo, N., Asmussen, K., Boesen, M., Rastiemadabadi, Z., Morsel-Carlsen, L., Møller, J. M., Krogh, N. S., & Østergaard, M. (2021). Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission. Rheumatology (Oxford, England), 60(12), 5549-5559. https://doi.org/10.1093/rheumatology/keab276
Terslev, Lene, et al. "Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission." Rheumatology (Oxford, England) vol. 60,12 (2021): 5549-5559. doi: https://doi.org/10.1093/rheumatology/keab276
Terslev L, Brahe CH, Hetland ML, Georgiadis S, Ellegaard K, Juul L, Huynh T, Døhn UM, Fana V, Møller T, Krabbe S, Ørnbjerg LM, Glinatsi D, Røgind H, Hansen A, Nørregaard J, Jacobsen S, Jensen DV, Manilo N, Asmussen K, Boesen M, Rastiemadabadi Z, Morsel-Carlsen L, Møller JM, Krogh NS, Østergaard M. Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission. Rheumatology (Oxford). 2021 Dec 01;60(12):5549-5559. doi: 10.1093/rheumatology/keab276. PMID: 33748831.
Copy
Download .nbib